dbacp07091
General Description
Peptide name : HB43-mut2
Source/Organism : Synthetic
Linear/Cyclic : Linear
Chirality : L
Sequence Information
Sequence : FAKLLAKLAKLLK
Peptide length: 13
C-terminal modification: Linear
N-terminal modification : Amidation
Non-natural peptide information:
Activity Information
Assay type : AlamarBlue assay
Assay time : 24-h
Activity : IC50 = 50 ± 3 μM
Cell line : HT-29
Cancer type : Colon Cancer
Other activity : Anticancer
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 1456.9 Dalton
Aliphatic index : 1.730
Instability index : -16.892
Hydrophobicity (GRAVY) : 0.8923
Isoelectric point : 10.477
Charge (pH 7) : 3.7561
Aromaticity : 7.692
Molar extinction coefficient (cysteine, cystine): (0, 0)
Hydrophobic/hydrophilic ratio : 2.25
hydrophobic moment : 1.9614
Missing amino acid : C,D,E,G,H,I,M,N,P,Q,R,S,T,V,W,Y
Most occurring amino acid : L
Most occurring amino acid frequency : 5
Least occurring amino acid : F
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (92., 0, 46.)
SMILES Notation: CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHHHHHHHHHH |
| Chou-Fasman (CF) | HHHHHHHHHHCCC |
| Neural Network (NN) | HHHHHHHHHHHHH |
| Joint/Consensus | HHHHHHHHHHHHH |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
CancerPPD : Not available
ApIAPDB : Not available
CancerPPD2 ID: 7264
Reference
1 : Herrera-León C, et al. The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide. Pharmaceutics. 2022; 14:(unknown pages). doi: 10.3390/pharmaceutics14051089
Literature
Paper title : The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide.
Doi : https://doi.org/10.3390/pharmaceutics14051089
Abstract : Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.